UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Chest, 2015-10, Vol.148 (4), p.1043-1054

2015

Volltextzugriff (PDF)

Validation of two predictive models for survival in pulmonary arterial hypertension

The European respiratory journal, 2015-07, Vol.46 (1), p.152-164

2015

Volltextzugriff (PDF)

Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study

The lancet respiratory medicine, 2016-04, Vol.4 (4), p.281-290

2016

Volltextzugriff (PDF)

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry

European journal of neurology, 2022-04, Vol.29 (4), p.1082-1090

2022

Volltextzugriff (PDF)

Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis

Multiple sclerosis and related disorders, 2023-03, Vol.71, p.104512-104512, Article 104512

2023

Volltextzugriff (PDF)

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

BMC neurology, 2023-07, Vol.23 (1), p.258-258, Article 258

2023

Volltextzugriff (PDF)

Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study

Multiple sclerosis and related disorders, 2022-12, Vol.68, p.104245-104245, Article 104245

2022

Volltextzugriff (PDF)

Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records

Frontiers in neurology, 2023-12, Vol.14, p.1253557-1253557

2023

Volltextzugriff (PDF)

Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients

Multiple sclerosis, 2022-10, Vol.28 (12), p.1937-1943

2022

Volltextzugriff (PDF)

From genomics to surveillance, prevention and control: New challenges for the African meningitis belt

Vaccine, 2006-05, Vol.24 (20), p.4279-4284

2006

Volltextzugriff (PDF)

Comparing the risk of serious infections in patients with and without MS: A German claims data analysis

Multiple sclerosis and related disorders, 2023-04, Vol.72, p.104583-104583, Article 104583

2023

Volltextzugriff (PDF)

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel

Multiple sclerosis and related disorders, 2022-12, Vol.68, p.104153-104153, Article 104153

2022

Volltextzugriff (PDF)

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

Frontiers in neurology, 2022-05, Vol.13, p.863105-863105

2022

Volltextzugriff (PDF)

Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry

Cardiology in the young, 2022-04, Vol.32 (4), p.597-605

2022

Volltextzugriff (PDF)

Meningitis epidemics in Africa: A brief overview

Vaccine, 2007-09, Vol.25, p.A3-A7

2007

Volltextzugriff (PDF)

The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry

Multiple sclerosis journal - experimental, translational and clinical, 2023-07, Vol.9 (3), p.20552173231187810-20552173231187810

2023

Volltextzugriff (PDF)

Deletion of the Correia element in the mtr gene complex of Neisseria meningitidis

Journal of medical microbiology, 2010-09, Vol.59 (9), p.1055-1060

2010

Volltextzugriff (PDF)

Workshop on vaccine pressure and Neisseria meningitidis , Annecy, France, 9–11 March 2005

Vaccine, 2007-05, Vol.25 (21), p.4125-4129

2007

Volltextzugriff (PDF)

European Congress of Vaccinology in Armed Forces, Paris, France, 16-17 October 2006

Military medicine, 2008-11, Vol.173 (11), p.vi-ix

2008

Volltextzugriff (PDF)

OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)

Chest, 2017-10, Vol.152 (4), p.A999-A1000

2017

Volltextzugriff (PDF)

Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab

Multiple sclerosis and related disorders, 2021-10, Vol.55, p.103203-103203, Article 103203

2021

Volltextzugriff (PDF)

MACITENTAN IN PORTOPULMONARY HYPERTENSION: REAL-WORLD EVIDENCE FROM THE OPSUMIT USERS REGISTRY

Chest, 2018-10, Vol.154 (4), p.987A-989A

2018

Volltextzugriff (PDF)

THE OPSUMIT® USERS REGISTRY: A GENDER SUBGROUP ANALYSIS OF PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1952-A1952

2018

Volltextzugriff (PDF)

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study

Multiple sclerosis and related disorders, 2023-11, Vol.79, p.104943-104943, Article 104943

2023

Volltextzugriff (PDF)

Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance

Revue neurologique, 2021-04, Vol.177, p.S108-S108

2021

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Validation of two predictive models for survival in pulmonary arterial hypertension

Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry

Electronic health record data for assessing risk of hospitalization for COVID-19: Methodological considerations applied to multiple sclerosis

The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry

Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study

Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records

Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients

From genomics to surveillance, prevention and control: New challenges for the African meningitis belt

Comparing the risk of serious infections in patients with and without MS: A German claims data analysis

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel

Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study

Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry

Meningitis epidemics in Africa: A brief overview

The socioeconomic impact of disability progression in multiple sclerosis: A retrospective cohort study of the German NeuroTransData (NTD) registry

Deletion of the Correia element in the mtr gene complex of Neisseria meningitidis

Workshop on vaccine pressure and Neisseria meningitidis , Annecy, France, 9–11 March 2005

European Congress of Vaccinology in Armed Forces, Paris, France, 16-17 October 2006

OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)

Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab

MACITENTAN IN PORTOPULMONARY HYPERTENSION: REAL-WORLD EVIDENCE FROM THE OPSUMIT USERS REGISTRY

THE OPSUMIT® USERS REGISTRY: A GENDER SUBGROUP ANALYSIS OF PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND SURVIVAL IN PULMONARY ARTERIAL HYPERTENSION

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study

Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance

Suchergebnisse filtern